24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
53.26% |
|
IL 2 RECEPTOR DYNAMICS |
35.87% |
|
ENZYME DYNAMICS |
10.87% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
27.27% |
|
ANTIBODY DYNAMICS |
26.14% |
|
IL 2 FORCE FIELD BENCHMARKING |
13.26% |
|
ALZHEIMERS |
12.31% |
|
ENZYME DYNAMICS |
8.71% |
|
IL 2 RECEPTOR DYNAMICS |
6.25% |
|
IL 2 DYNAMICS SIMULATIONS |
6.06% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
21.88% |
|
ANTIBODY DYNAMICS |
16.21% |
|
ANTIBODY AFFINITY MATURATION |
15.9% |
|
ANTIBODY DYNAMICS SIMULATION |
12.15% |
|
IL 2 FORCE FIELD BENCHMARKING |
10.02% |
|
IL 2 DYNAMICS SIMULATIONS |
6.96% |
|
IL 2 RECEPTOR DYNAMICS |
4.28% |
|
ALZHEIMERS |
4.04% |
|
ENZYME DYNAMICS |
3.69% |
|
ATSTP10 SUCROSE TRANSPORT |
1.54% |
|
IL 2 MOLECULAR DYNAMICS |
1.41% |
|
IL2 RECEPTOR DYNAMICS |
.96% |
|
ANTIBODY MATURATION SIMULATION |
.96% |